.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Metastasis remains the leading cause of cancer-related mortality worldwide. Even after modern treatment, dormant tumor cells (DTCs) often persist at distant sites in a quiescent state. These cells stop dividing but remain viable for years. Consequently, they frequently cause late recurrence by evading common therapies. Furthermore, they interact with the surrounding microenvironment to stay hidden. Understanding these mechanisms is essential for improving clinical outcomes in oncology. Researchers are now focusing on the complex relationship between these cells and the immune system.
Research suggests that dormant cells evade the immune system through several complex pathways. Specifically, these cells often downregulate MHC class I molecules. This change makes them invisible to cytotoxic T lymphocytes. Moreover, the scarcity of these cells makes physical contact with immune cells very rare. This phenomenon creates a significant barrier to effective immune-mediated clearance. Additionally, the stromal and vascular components of the niche protect these cells from detection. For instance, certain macrophages can promote dormancy or trigger eventual reactivation. Therefore, the tumor microenvironment serves as a shield against constant immune surveillance. Scientific advances now focus on disrupting this equilibrium. As a result, new immunotherapies aim to eliminate the reservoir of hidden cells. Targeting the niche might prevent the awakening of metastatic cells in the future. Clinicians must consider these hidden threats when planning long-term follow-up care.
Chemotherapy typically targets actively dividing cells. Since these cells remain in a quiescent or resting state, they do not respond to treatments aimed at rapid proliferation.
The microenvironment provides protective niches that regulate immune tolerance. It also physically separates tumor cells from immune players, which significantly reduces the likelihood of detection.
Recent studies suggest that T-cell-based vaccinations or CAR T-cell therapies could overcome the scarcity of cell interactions. These methods might help the immune system identify and kill hidden reservoirs.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Always seek the advice of a qualified physician or other health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Tiwary K et al. Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance. Mol Oncol. 2026 Apr 17. doi: 10.1002/1878-0261.70259. PMID: 41994877.
Goddard ET et al. Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies. Cancer Cell. 2024;42(1):119-134. doi: 10.1016/j.ccell.2023.12.011.
Adam-Artigues A, et al. Immune evasion by dormant disseminated cancer cells: A Fermi paradox? Cancer Cell. 2024;42(1):13-15. doi: 10.1016/j.ccell.2023.12.017.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A review of how dormant tumor cells (DTCs) hide in the microenvironment and evade immune surveillance, leading to late cancer recurrence and survival....
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
